[Fansidar-induced maculopathy and dermatitis exfoliativa].
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D008266:Macula Lutea / Q000187:drug effects*; D011739:Pyrimethamine / Q000009:adverse effects*; D012164:Retinal Diseases / Q000139:chemically induced*; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine
Fansidarindusert makulopati og dermatitis exfoliativa.